We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$104M
Cap. Flow %
2.08%
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7 years
Top 10 Avg Time Held Equity + Options
2.9 years
Top 20 Avg Time Held Equity + Options
3.8 years
Avg Time Held Equity only
4.7 years
Top 10 Avg Time Held Equity only
2.9 years
Top 20 Avg Time Held Equity only
3.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.71%
2 Technology 17.21%
3 Healthcare 9.68%
4 Financials 7.2%
5 Communication Services 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CDXS icon
3276
Codexis
CDXS
$145M
$488 ﹤0.01%
200
– –
2024 Q1
5 quarters
WWW icon
3277
Wolverine World Wide
WWW
$1.62B
$488 ﹤0.01%
27
– –
2021 Q1
17 quarters
IRLA
3278
IRulya Therapeutics Inc. Common Stock
IRLA
$30.5M
$487 ﹤0.01%
1
– –
2020 Q1
21 quarters
BUR icon
3279
Burford Capital
BUR
$718M
$485 ﹤0.01%
34
-43
-56% -$562
2024 Q3
3 quarters
PANL icon
3280
Pangaea Logistics
PANL
$521M
$484 ﹤0.01%
103
+30
+41% +$133
2025 Q1
1 quarter
OPEN icon
3281
Opendoor
OPEN
$2.09B
$483 ﹤0.01%
936
-5,283
-85% -$3.82K
2021 Q2
16 quarters
ZVIA icon
3282
Zevia
ZVIA
$86.6M
$483 ﹤0.01%
+150
New +$395
2025 Q2
0 quarters
CGEM icon
3283
Cullinan Oncology
CGEM
$882M
$482 ﹤0.01%
+64
New +$514
2025 Q2
0 quarters
CRBG icon
3284
Corebridge Financial
CRBG
$15.1B
$470 ﹤0.01%
13
-4
-24% -$124
2024 Q1
5 quarters
SBCF icon
3285
Seacoast Banking Corp of Florida
SBCF
$3.09B
$470 ﹤0.01%
+17
New +$420
2025 Q2
0 quarters
BCO icon
3286
Brink's
BCO
$4.35B
$446 ﹤0.01%
5
-55
-92% -$4.79K
2023 Q4
6 quarters
RGS icon
3287
Regis Corp
RGS
$71.9M
$446 ﹤0.01%
20
– –
2024 Q4
2 quarters
LEVI icon
3288
Levi Strauss
LEVI
$7.77B
$444 ﹤0.01%
24
-83
-78% -$1.38K
2025 Q1
1 quarter
FLNA icon
3289
Filana Therapeutics
FLNA
$35.3M
$442 ﹤0.01%
244
– –
2021 Q1
17 quarters
GPI icon
3290
Group 1 Automotive
GPI
$2.88B
$437 ﹤0.01%
1
-1
-50% -$420
2024 Q2
4 quarters
NTGR icon
3291
NETGEAR
NTGR
$601M
$436 ﹤0.01%
15
– –
2024 Q3
3 quarters
OESX icon
3292
Orion Energy Systems
OESX
$96.6M
$431 ﹤0.01%
72
+19
+36% +$129
2021 Q1
17 quarters
CXW icon
3293
CoreCivic
CXW
$3.08B
$421 ﹤0.01%
20
– –
2023 Q2
8 quarters
MTW icon
3294
Manitowoc
MTW
$797M
$421 ﹤0.01%
35
-4
-10% -$39
2025 Q1
1 quarter
TIPX icon
3295
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.08B
$421 ﹤0.01%
22
-1,584
-99% -$30.1K
2023 Q2
8 quarters
MSSM icon
3296
Morgan Stanley Pathway Small-Mid Cap Equity ETF
MSSM
$683M
$420 ﹤0.01%
+9
New +$391
2025 Q2
0 quarters
YOU icon
3297
Clear Secure
YOU
$4.61B
$416 ﹤0.01%
15
-24
-62% -$611
2024 Q3
3 quarters
UDMY icon
3298
DELISTED
Udemy
UDMY
$415 ﹤0.01%
+59
New +$407
2025 Q2
0 quarters
HRTX icon
3299
Heron Therapeutics
HRTX
$71.9M
$414 ﹤0.01%
200
– –
2020 Q1
21 quarters
EVLV icon
3300
Evolv Technologies
EVLV
$748M
$412 ﹤0.01%
66
– –
2025 Q1
1 quarter

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.